Vanguard Information Technology ETF (VGT) — ()

4 Growth ETFs With Double-Digit Upside Potential in 2025

Growth stocks and ETFs had a rough start in 2025, but with headwinds giving way to tailwinds, the second half of the year can be a good one for investors.

Big ETF Inflows of Last Week: QQQ, IBIT & More

QQQ and IBIT led last week's $17B ETF inflows, as investors piled into tech, Bitcoin, and gold amid market resilience.

Vergent Bioscience Presents Phase 2B VISUALIZE Results Demonstrating Abenacianine for Injection (VGT-309) with Intraoperative Molecular Imaging Improved Tumor Visualization During Lung Surgery

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor targeted imaging agents, announced new data being presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. These results …

VGT: I Want More Diversification

VGT's extreme concentration in its top three holdings undermines the diversification benefit I expect from an ETF. Current tech sector valuations are historically high, leaving little room for further multiple …

The Nasdaq Just Soared 30% From Its 2025 Low: 3 Vanguard ETFs to Buy Now

The Nasdaq Composite (^IXIC 0.52%) closed Wednesday at 19,146.81 -- a staggering 29.5% rally from its 52-week intraday low of 14,784.03 on April 7.

Select Live Vanguard IT ETF (VGT): Tech Stocks Buoy Market Sentiment Amid Renewed Economic Optimism

The markets are extending their gains in this midweek session. Technology stocks are buoying wider market sentiment.

Live Vanguard IT ETF (VGT): Markets Return to Volatile Ways Despite China Trade Progress

The markets came out of the gate higher across the board but those gains have evaporated.

Live Vanguard IT ETF (VGT): Tech Stocks Rise on Trade Deal Tailwinds

Tech stocks are joining in on today's market gains on positive trade developments between the U.S.

Vergent Bioscience to Present Data on Abenacianine for Injection (VGT-309) at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that an abstract on abenacianine for injection (VGT-309) will be featured at the 2025 American Society of Clinical …

Live Vanguard IT ETF (VGT): Markets Dig in Heels Until Economy Is in Clear

The markets remain under pressure, including technology stocks, as the Fed meets to discuss interest rates.

Live Vanguard IT ETF (VGT): Markets Blink on Tariff Uncertainty in Mixed Showing

Tech stocks remain under pressure, including a 2% decline in Apple stock, while the Dow Jones Industrial Average is eking out a slight gain.

Live Vanguard IT ETF (VGT): Big Tech Capex Plans Embolden Markets

The markets are on pace to finish the week on a positive note after all is said and done.

Live Vanguard IT ETF (VGT): Tech Stocks Power Impressive Market Performance on AI Prowess

Citi analyst Christopher Danely remains bullish on AI spending, publishing a report indicating that the impact of the tariffs on tech capex have been overdone.

Live Vanguard IT ETF (VGT): Markets Embroiled in Selling amid Economic Slowdown

Throwing yet another wrench into the markets, there is labor market data to process.

Tips for investing in tech now

Big tech has dominated the markets, but with tariffs and market uncertainty, what should investors do with the sector now? Ivana Delevska, Spear Invest Founder and CIO, joins Wealth to …

VGT: In A Rut, Mixed Analysis, Hold Tight

Vanguard Information Technology Index Fund (VGT) is down 12% in the last month but has gained 3.5% over the last year. VGT is heavily weighted in Apple, Nvidia, and Microsoft, …

5 Sector ETFs Set for Q1 Earnings Growth Amid Tariff Woes

We highlight ETFs from the sectors expected to post Q1 earnings growth that could make great plays amid tariff woes.

1 Top Technology ETF to Buy and 1 to Avoid

The technology-oriented Nasdaq 100 index is back into correction territory, down 10.5% after hitting an all-time high last month.

2 Wonderful High-Tech ETFs That Still Look Like Bargains Right Now

After a bit of a rebound, the Nasdaq Composite index is no longer officially in correction territory, for now at least, down by just 9% from the recent highs as …

Prediction: These 2 ETFs Will Outperform the Market This Year

With markets in flux, finding exchange traded funds (ETFs) that have the potential to outperform the broader indices is something most investors are after.

Shifting Tides in Leadership: Markets Play Defense

Talk about a topsy-turvy market. Tuesday's tariffs sparked more market jitters.

Prediction: These 2 Vanguard ETFs Will Trounce the Nasdaq-100 This Year

2 Simple ETFs to Buy With $1,000 and Hold for a Lifetime

Exchange-traded funds (ETFs) are fantastic investment vehicles that allow you to own a basket of stocks without picking them individually. ETFs also pool the funds of many investors together, allowing …

Prediction: These 2 Vanguard ETFs Will Beat the S&P 500 in 2025

The S&P 500 has been a solid benchmark that has produced annualized double-digit returns for many years.